| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | EP1922315A1 Preparation of an atorvastatin intermediate |
| 05/21/2008 | EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 05/21/2008 | EP1831191B1 Chroman derivatives and their use as 5-ht receptor ligands |
| 05/21/2008 | EP1737838B1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
| 05/21/2008 | EP1603893B1 Ep4 receptor antagonists |
| 05/21/2008 | EP1562595B1 Diaryl ethers as opioid receptor antagonists |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1284734B1 Isoquinoline derivatives as protein kinase inhibitors |
| 05/21/2008 | EP1183253B1 C7 ester substituted taxanes as antitumor agents |
| 05/21/2008 | CN101184728A Peptide deformylase (PDF) inhibitors 4 |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/20/2008 | US7375222 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375115 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 05/20/2008 | US7375105 Neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine, cardiac hypertrophy |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2395717C Fused imidazolium derivatives |
| 05/20/2008 | CA2298461C Heterocyclic substituted 4-benzoyl-pyrazole as herbicides |
| 05/15/2008 | WO2008058037A1 Compounds and compositions as protein kinase inhibitors |
| 05/15/2008 | WO2008057254A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | WO2008055950A1 Novel inhibitors of glutaminyl cyclase |
| 05/15/2008 | WO2008055947A1 Novel inhibitors of glutaminyl cyclase |
| 05/15/2008 | WO2008055808A1 Indole and benzofuran 2-carboxamide derivatives |
| 05/15/2008 | WO2008055710A1 Indole and indazole derivatives as anti-inflammatory agents |
| 05/15/2008 | WO2008055709A1 Indazole and indole derivatives as anti -inflammatory agents |
| 05/15/2008 | WO2008037789A8 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives |
| 05/15/2008 | WO2008024492A3 Indolinone phenylaminopropanol derivatives and process for the preparation thereof |
| 05/15/2008 | WO2008012227A3 Pyrazoles as glucokinase activators |
| 05/15/2008 | US20080114172 Synthesis of Selected Stereoisomers of Certain Substituted Alcohols |
| 05/15/2008 | US20080114052 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114047 Mycobacterium tuberculosis infection; protozoan pathogens; fungal pathogens; 2-((4-Amidinobenzofuran-2-yl)methyl)benzofuran-4-carboxamidine; 4,5-Dihydro-2-(2-(2-(5-(4,5-dihydro-1H-imidazol-2-yl)benzofuran-2-yl)ethyl)benzofuran-5-yl)-1H-imidazole |
| 05/15/2008 | US20080114040 Epothilone Derivatives |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114030 Diarymethyl and related compounds |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113968 Substituted piperazines and diazepanes |
| 05/15/2008 | US20080113022 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
| 05/15/2008 | US20080112866 Functionalized ionic liquids, and methods of use thereof |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |
| 05/15/2008 | CA2668959A1 Indole and benzofuran 2-carboxamide derivatives |
| 05/15/2008 | CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators |
| 05/15/2008 | CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | CA2668190A1 Compounds and compositions as protein kinase inhibitors |
| 05/15/2008 | CA2667644A1 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 05/14/2008 | EP1921068A1 Indazole and indole derivatives as anti-inflammatory agents |
| 05/14/2008 | EP1921067A1 Indole and indazole derivatives as anti-inflammatory agents |
| 05/14/2008 | EP1921066A1 Pyridylphenol compound and use thereof |
| 05/14/2008 | EP1919890A1 Pyrazolone derivatives for the treatment of tuberculosis |
| 05/14/2008 | EP1919881A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders |
| 05/14/2008 | EP1919869A1 Novel indole compounds |
| 05/14/2008 | EP1756064B1 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 05/14/2008 | EP1667991B1 Quinazoline derivatives as tyrosine kinase inhibitors |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors |
| 05/14/2008 | CN101180291A Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists |
| 05/14/2008 | CN100388201C Program code size partitioning system and method for multiple memory multi-processing systems |
| 05/14/2008 | CN100387127C Fungicides |
| 05/13/2008 | US7371874 5-lipoxygenase inhibitor, leukotriene antagonist; rheumatoid arthritis, colitis, asthma, psoriasis; coupling 6-amino-2-methyl-2'methyl(aminoprtotecting)-2H-7,8-disubstituted benzopyran with backbone amide linker, coupling with radical to N atom; deprotection, sulfonation, cleavage with a dichloromethane |
| 05/13/2008 | US7371865 Reacting an organophosphouus compound with metallized alkane; forming atorvastatin, lorastatin, pitavastatin, fluvastatin |
| 05/13/2008 | US7371860 PNA monomer and precursor |
| 05/13/2008 | US7371859 Peptide nucleic acid monomers; 1-(4-(benzothiazolyl-, benzoxazolyl-, benzofuranyl-, and benzothiophenyl- sulfonyl)piperidin-3-one-1-ylcarbonylmethyl)adenines; suitable for automatic and parallel synthesis; increased yields |
| 05/13/2008 | US7371855 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 05/13/2008 | US7371778 Spiro and dispiro 1,2,4-trioxolane antimalarials |
| 05/13/2008 | US7371777 Such as 2-(3-{[(4-ethoxybenzoyl)amino]methyl}-4-ethoxybenzyl)-tetrahydro-2-furancarboxylic acid; antihyperglycemia and antihyperlipemia action |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371762 Infections caused by Gram positive and/or negative pathogens |
| 05/13/2008 | US7371756 Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/13/2008 | US7371753 Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
| 05/13/2008 | US7371470 Pyran derivative |
| 05/13/2008 | CA2293470C Benzimidazole derivatives |
| 05/08/2008 | WO2008053812A1 Cyanopyridine derivative and medicinal use thereof |
| 05/08/2008 | WO2008053319A1 Amide resorcinol compounds |
| 05/08/2008 | WO2008053300A1 Pyrazoline compounds as mineralocorticoid receptor antagonists |
| 05/08/2008 | WO2008052934A1 Novel substituted pyrimidines as cysteine protease inhibitors |
| 05/08/2008 | WO2008052899A1 Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
| 05/08/2008 | WO2008052808A1 Cyclic phenyl-substituted indazols, a process for their production and their use as anti-inflammatory agents |
| 05/08/2008 | WO2008034891A3 Novel genes related to glutaminyl cyclase |
| 05/08/2008 | US20080108822 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's |
| 05/08/2008 | US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation |
| 05/08/2008 | US20080108690 chromenone derivatives of nitrogen-, oxygen- or sulfur-containing saturated heterocycles; preparation by cyclizing benzoyl intermediates; antiproliferative agents; 2-(2-Chloro-phenyl)-8-(2-hydroxymethyl-1-methyl-pyrrolidin-3-yl)-5,7-dimethoxy-chromen-4-one |
| 05/08/2008 | US20080108678 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; 4-Methylsulfanyl-N-{2-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-acetylamino]-cyclohexyl}-benzamide |
| 05/08/2008 | US20080108662 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 05/08/2008 | US20080108660 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 05/08/2008 | US20080108657 Used to treat cancer including leukemia, mesothelioma, lung cancer, colorectal cancer, breast cancer, ovarian cancer, prostate cancer, melanoma, cancer of the uterine body and cancer of the central nervous system; nontoxic |
| 05/08/2008 | US20080108626 (5-amino-1-phenyl-1H-pyrazole)-(3-Amino-N-isoxazol-3-yl-4-methyl)-benzamide; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 05/08/2008 | US20080108620 N-(4-{(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-QUINOLIN-3-YL-1H-PYRAZOL-1-YL]ETHYL}BENZOYL)- beta -ALANINE; glucagon receptor antagonists; antidiabetic agent; insulin resistance and its complications, including coronary heart disease, stroke, hypertension, nephropathy, neuropathy, retinopathy; atherosclerosis |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108608 Pyrimidines With Tie2 (Tek) Activity |
| 05/08/2008 | US20080108601 anticancer agents; catalytic hydrogenation |
| 05/08/2008 | US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108141 2,3-diaminonaphthalene reacts with nitric oxide to give fluorescent naphthalenetriazole |